Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Critical Reviews in Microbiology|October 2, 2010
Candida tropicalis in human diseaseLouis Yi Ann Chai, David W Denning, Peter WarnThe Journal of Antimicrobial Chemotherapy|February 6, 2015
SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDIAbdul Sattar, Pia Thommes, Lloyd Payne, et al.The Journal of Antimicrobial Chemotherapy|December 22, 2016
A single dose of epidermicin NI01 is sufficient to eradicate MRSA from the nares of cotton ratsSamantha Halliwell, Peter Warn, Abdul Sattar, et al.Journal of Clinical Microbiology|February 5, 2010
Detection of Aspergillus fumigatus in a rat model of invasive pulmonary aspergillosis by real-time nucleic acid sequence-based amplificationYanan Zhao, Steven Park, Peter Warn, et al.Plos One|October 15, 2011
Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™Jagdishbhai L Italia, Andrew Sharp, Katharine C Carter, et al.The Journal of Antimicrobial Chemotherapy|July 29, 2020
Intermittent micafungin for prophylaxis in a rat model of chronic Candida albicans gut colonizationPeter Warn, Pia Thommes, Andrew Sharp, et al.Yeast (Chichester, England)|March 25, 2005
Deletion of PDE2, the gene encoding the high-affinity cAMP phosphodiesterase, results in changes of the cell wall and membrane in Candida albicansWon Hee Jung, Peter Warn, Enrico Ragni, et al.Antimicrobial Agents and Chemotherapy|April 8, 2020
Pharmacokinetics-Pharmacodynamics of Enmetazobactam Combined with Cefepime in a Neutropenic Murine Thigh Infection ModelFabian Bernhard, Rajesh Odedra, Sylvie Sordello, et al.Antimicrobial Agents and Chemotherapy|August 17, 2016
Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and VancomycinPeter Warn, Pia Thommes, Abdul Sattar, et al.The Journal of Antimicrobial Chemotherapy|October 24, 2018
Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section TerreiMichaela Lackner, Mike Birch, Verena Naschberger, et al.Pageof 3